Celgene has decided to stop the clinical trials of Crohn's disease drug GED-0301 (mongersen) due to lack of meaningful results. The firm has decided to terminate the ...

Tenofovir exalidex, a novel prodrug of tenofovir, appeared safe and well-tolerated in patients with hepatitis B, according to a presentation at The Liver Meeting 2017...

 Almac Clinical Technologies, a global leader in technology-enabled solutions for managing clinical trial patient and supplies data, has extended the functionality of...

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services in the United States, announced today that it has opened its first inte...

Biotech company Aimmune Therapeutics have decided to try out its peanut allergy medication in combination with big pharma Sanofi/Regeneron’s Dupixent (dupilumab). Rec...

A team of clinicians and researchers from the SingHealth Duke-NUS Academic Medical Centre (AMC) and pharmaceutical firm GSK are conducting a study to improve the care...

First testing in human subjects with radioactive cisplatin CISSPECT scheduled to start soon   PETTEN – NRG has developed a radioactive platinum isotope that may ...

XBiotech Inc. announced today the enrolment of the first patient into a Phase I single arm study evaluating the maximum tolerated dose of Onivyde® (Irinotecan liposom...

Ardelyx has released positive results from its second Phase 3 study of tenapanor, dubbed T3MPO-2, for irritable bowel syndrome with constipation (IBS-C). The study hi...